Navigation Links
Compass Diversified Holdings Announces First Quarter 2013 Earnings and Conference Call Information
Date:4/24/2013

WESTPORT, Conn., April 24, 2013 /PRNewswire/ -- Compass Diversified Holdings (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that it plans to release financial results for the first quarter ended March 31, 2013, on Tuesday, May 7, 2013, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, May 8, 2013 at 9:00 a.m. ET.

The conference call will feature remarks by Alan Offenberg , Chief Executive Officer, James J. Bottiglieri , Chief Financial Officer, and Elias J. Sabo , a founding partner of Compass Group Management LLC. To participate in the call, please dial (888) 466-4462 (domestic) or (719) 457-2727 (international). The passcode is 5197923. Please dial into the call at least five minutes before the scheduled start time.  

The conference call will also be available via a live listen-only webcast and can be accessed through the Investor Relations section of CODI's website, www.compassdiversifiedholdings.com. Please allow extra time prior to the call to visit the site and download any necessary software that may be needed to listen to the Internet broadcast.

For interested individuals unable to join the live conference call, a replay of the call will be available through May 15, 2013 at (888) 203-1112 (domestic) or (719) 457-0820 (international). The passcode for the call and replay is 5197923. An online archive of the webcast will be available on the Company's website for 30 days following the call.

About Compass Diversified Holdings ("CODI")
CODI owns and manages a diverse family of established North American middle market businesses. Each of its eight c
'/>"/>

SOURCE Compass Diversified Holdings
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Compass Diversified Holdings Expands Term Loan Facility by $30 Million and Lowers Interest Rate by 1.25%
2. Compass Diversified Holdings Provides Shareholders with 2012 Tax Information
3. Compass Diversified Holdings Announces Third Quarter 2012 Earnings and Conference Call Information
4. H. D. Smith Establishes Specialty Solutions Organization And Realigns Senior Leadership To Support Growing Geographic Reach, Diversified Businesses
5. Hill-Rom Holdings, Inc. to Host Investor Conference May 7
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
7. Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
8. Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast
9. Organovo Holdings, Inc. Announces Change of Fiscal Year
10. PDP Holdings, LLC Announces Support for Health and Human Services Office of Inspector General Guidance
11. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... , Nov. 20, 2014  Edwards Lifesciences Corporation (NYSE: ... science of heart valves and hemodynamic monitoring, announced today ... 2014 to support a strong launch of Edwards Lifesciences ... and to improve the global communities where its employees ... global corporate giving will exceed $8 million, including more ...
(Date:11/21/2014)... 2014  RedRick Technologies, a provider of ergonomic ... environment guidance, has helped the new Penn Musculoskeletal ... which may also serve as a model for ... "In line with the tenets of ... Imaging 3.0 ™ initiative, the new reading ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3
(Date:11/22/2014)... “Due to my knee replacement surgery, I had ... “While using the ice grip attachment, I noticed how dangerous ... to be a safer way to prevent possible injuries, so ... SPIKE BLOCK offers added safety and stability in slick and ... injuries and damage associated with traditional spiked ice grips. As ...
(Date:11/22/2014)... 2014 Nocturia is defined by ... that the individual has to wake at night ... “Nocturia – Pipeline Review, H2 2014” provides comprehensive ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ...
(Date:11/22/2014)... Melbourne, Australia (PRWEB) November 22, 2014 ... for the declined slightly in 2009-10, due to ... Dairy Product Manufacturing industry products amid the ... outweigh the growing strength of Australian dairy manufacturers ... demand for dairy products outweighed supply growth, primarily ...
(Date:11/22/2014)... New York (PRWEB) November 22, 2014 ... on behalf of patients who allegedly developed Type 2 ... in the federal multidistrict litigation now underway in U.S. ... reports. According to court documents, the litigation will convene ... a.m. The Court has directed Lead Counsel for Plaintiffs ...
(Date:11/22/2014)... November 22, 2014 Recently, UWDress.com is ... wedding guest dresses . In addition, the company has ... , As a leading online supplier of wedding ... beautiful outfits. The unusual best wedding guest gowns are ... the amazing designs, this new selection is famous for ...
Breaking Medicine News(10 mins):Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Best Wedding Guest dresses Introduced by UWDress.com 2
... can reduce hot flashes effectively. The good news is that cool ... , ... Ann Arbor, MI (PRWEB) July 21, 2008 -- The hot ... debating merits of synthetic or bio-identical hormones. Too much complicated information overwhelms ...
... New data from a study of patients with treatment-resistant ... subcallosal cingulate region (SCG or Cg25) of the brain ... significant improvement in patients as early as one month ... improvement over time. , The data are ...
... Eileen T. Kennedy DSc, Dean of Tufts University,s Gerald ... and Policy announced the 3rd Annual Friedman School Symposium, ... issues facing industry, policy-makers, academics and thought leaders in ... Boston, September 24th to 26th, 2008. , Fifteen experts ...
... iCAD, Inc. (Nasdaq:,ICAD), an industry-leading provider of ... its previously announced,agreement to purchase the principal assets ... in White Plains, NY. The,purchase price was $5 ... shares of iCAD common stock. The number of ...
... leucoanthocyanidins and anthocyanidins are natural, ... antioxidant properties, IRVINE, Calif., July 21 ... phytochemical reference standards and,contract research, announced today its ... agreement with The Research Foundation of the,State University ...
... PITTSBURGH, July 21 Mylan Inc. (NYSE: ... Crookshank as vice president -,Investor Relations and as ... to Chief Financial Officer Edward J. Borkowski, Crookshank ... as for the,development and direction of activities that ...
Cached Medicine News:Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 3Health News:Promising results in deep brain stimulation for patients with treatment-resistant depression 2Health News:Promising results in deep brain stimulation for patients with treatment-resistant depression 3Health News:'Nutrition Agenda 2008' is focus of Tufts Friedman School Symposium 2Health News:'Nutrition Agenda 2008' is focus of Tufts Friedman School Symposium 3Health News:iCAD Completes Acquisition of CAD Sciences 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 3Health News:Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations 2
... Triad Plus PVP-I Scrub swabsticks ... surgical cleanser containing to prevent ... USP solution equivalent to 0.75% ... to kill skin surface pathogens, ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. Povidone Iodine Scrub is ...
Medicine Products: